Polar Capital LLP historic quarter change: Foreign Stocks, Added
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 13 quarters from 2013-06-30 to 2016-09-30, Polar Capital LLP opened 9 positions, added to 31, reduced 30 and sold out of 4.
- Q3 2016: Stock NTES; Country of operation —; Class SPONSORED ADR; Shares before 113,119.
- Q3 2016: Stock BIDU; Country of operation —; Class SPON ADR REP A; Shares before 75,600.
- Q3 2016: Stock TEVA; Country of operation —; Class ADR; Shares before 217,567.
- Q3 2016: Stock HIMX; Country of operation —; Class SPONSORED ADR; Shares before 1,037,351.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1439303), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-15); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-13); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-12); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-07); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-11); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2008-06-30.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | NTES
NETEASE INC | | SPONSORED ADR | 113,119 | 113,969 | +850 | $21,856,000 | $27,443,000 | +$5,587,000 | 2016-11-14 |
|---|
| Q3 2016 | BIDU
BAIDU INC | | SPON ADR REP A | 75,600 | 95,257 | +19,657 | $12,485,000 | $17,343,000 | +$4,858,000 | 2016-11-14 |
|---|
| Q3 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 217,567 | 290,000 | +72,433 | $10,925,000 | $13,343,000 | +$2,418,000 | 2016-11-14 |
|---|
| Q3 2016 | HIMX
HIMAX TECHNOLOGIES INC | | SPONSORED ADR | 1,037,351 | 1,156,051 | +118,700 | $8,564,000 | $9,930,000 | +$1,366,000 | 2016-11-14 |
|---|
| Q3 2016 | MTLS
MATERIALISE NV | | SPONSORED ADS | 166,991 | 246,790 | +79,799 | $1,191,000 | $1,898,000 | +$707,000 | 2016-11-14 |
|---|
| Q3 2016 | ADAPY
ADAPTIMMUNE THERAPEUTICS PLC | United Kingdom | SPONDS ADR | 50,000 | 60,000 | +10,000 | $408,000 | $423,000 | +$15,000 | 2016-11-14 |
|---|
| Q2 2016 | NTES
NETEASE INC | | SPONSORED ADR | 75,702 | 113,119 | +37,417 | $10,867,000 | $21,856,000 | +$10,989,000 | 2016-08-15 |
|---|
| Q2 2016 | MTLS
MATERIALISE NV | | SPONSORED ADS | 140,779 | 166,991 | +26,212 | $1,071,000 | $1,191,000 | +$120,000 | 2016-08-15 |
|---|
| Q1 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 736,600 | 862,567 | +125,967 | $48,347,000 | $46,153,000 | -$2,194,000 | 2016-05-16 |
|---|
| Q4 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 215,000 | 736,600 | +521,600 | $12,136,000 | $48,347,000 | +$36,211,000 | 2016-02-16 |
|---|
| Q4 2015 | BIDU
BAIDU INC | | SPON ADR REP A | 107,671 | 141,168 | +33,497 | $14,795,000 | $26,686,000 | +$11,891,000 | 2016-02-16 |
|---|
| Q4 2015 | HIMX
HIMAX TECHNOLOGIES INC | | SPONSORED ADR | 1,578,421 | 1,847,489 | +269,068 | $12,572,000 | $15,139,000 | +$2,567,000 | 2016-02-16 |
|---|
| Q4 2015 | SIMO
SILICON MOTION TECHNOLOGY CO | | SPONSORED ADR | 568,509 | 568,645 | +136 | $15,521,000 | $17,831,000 | +$2,310,000 | 2016-02-16 |
|---|
| Q4 2015 | MTLS
MATERIALISE NV | | SPONSORED ADS | 167,931 | 170,631 | +2,700 | $1,271,000 | $1,203,000 | -$68,000 | 2016-02-16 |
|---|
| Q3 2015 | SIMO
SILICON MOTION TECHNOLOGY CO | | SPONSORED ADR | 301,271 | 568,509 | +267,238 | $10,426,000 | $15,521,000 | +$5,095,000 | 2015-11-16 |
|---|
| Q3 2015 | HIMX
HIMAX TECHNOLOGIES INC | | SPONSORED ADR | 1,143,776 | 1,578,421 | +434,645 | $9,179,000 | $12,572,000 | +$3,393,000 | 2015-11-16 |
|---|
| Q3 2015 | NTES
NETEASE INC | | SPONSORED ADR | 86,992 | 127,535 | +40,543 | $12,599,000 | $15,320,000 | +$2,721,000 | 2015-11-16 |
|---|
| Q3 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 191,000 | 215,000 | +24,000 | $11,290,000 | $12,136,000 | +$846,000 | 2015-11-16 |
|---|
| Q2 2015 | SGMOQ
SANGAMO BIOSCIENCES INC | United States | COM | 34,326 | 36,159 | +1,833 | $538,000 | $401,000 | -$137,000 | 2015-08-14 |
|---|
| Q1 2015 | HIMX
HIMAX TECHNOLOGIES INC | | SPONSORED ADR | 311,888 | 1,676,508 | +1,364,620 | $2,511,000 | $10,612,000 | +$8,101,000 | 2015-05-15 |
|---|
| Q1 2015 | BIDU
BAIDU INC | | SPON ADR REP A | 161,589 | 188,616 | +27,027 | $36,828,000 | $39,308,000 | +$2,480,000 | 2015-05-15 |
|---|
| Q1 2015 | SIMO
SILICON MOTION TECHNOLOGY CO | | SPONSORED ADR | 453,177 | 490,483 | +37,306 | $10,716,000 | $13,184,000 | +$2,468,000 | 2015-05-15 |
|---|
| Q4 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 360,213 | 750,000 | +389,787 | $19,361,000 | $43,133,000 | +$23,772,000 | 2015-02-17 |
|---|
| Q4 2014 | SIMO
SILICON MOTION TECHNOLOGY CO | | SPONSORED ADR | 368,753 | 453,177 | +84,424 | $9,934,000 | $10,716,000 | +$782,000 | 2015-02-17 |
|---|
| Q2 2014 | BIDU
BAIDU INC | | SPON ADR REP A | 132,576 | 190,491 | +57,915 | $20,200,000 | $35,586,000 | +$15,386,000 | 2014-08-12 |
|---|
| Q2 2014 | HIMX
HIMAX TECHNOLOGIES INC | | SPONSORED ADR | 791,061 | 1,077,995 | +286,934 | $9,109,000 | $7,395,000 | -$1,714,000 | 2014-08-12 |
|---|
| Q1 2014 | BIDU
BAIDU INC | | SPON ADR REP A | 91,754 | 132,576 | +40,822 | $16,319,000 | $20,200,000 | +$3,881,000 | 2014-05-07 |
|---|
| Q4 2013 | HIMX
HIMAX TECHNOLOGIES INC | | SPONSORED ADR | 724,268 | 1,029,718 | +305,450 | $7,239,000 | $15,147,000 | +$7,908,000 | 2014-02-11 |
|---|
| Q4 2013 | NICE
NICE SYS LTD | | SPONSORED ADR | 248,750 | 278,150 | +29,400 | $10,291,000 | $11,385,000 | +$1,094,000 | 2014-02-11 |
|---|
| Q3 2013 | BIDU
Baidu | | SPON ADR REP A | 17,459 | 100,954 | +83,495 | $1,650,000 | $15,659,000 | +$14,009,000 | 2013-11-14 |
|---|
| Q3 2013 | HDB
HDFC Bank | | ADR REPS 3 SHS | 29,000 | 33,900 | +4,900 | $1,051,000 | $1,043,000 | -$8,000 | 2013-11-14 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |